Mangiferin Upregulates Glyoxalase 1 Through Activation of Nrf2/ARE Signaling in Central Neurons Cultured with High Glucose. (Q48667618)

14 February 2018

title

Mangiferin Upregulates Glyoxalase 1 Through Activation of Nrf2/ARE Signaling in Central Neurons Cultured with High Glucose. (English)

1 reference

14 February 2018

author name string

Yao-Wu Liu

1

1 reference

14 February 2018

Ya-Qin Cheng

2

1 reference

14 February 2018

Xiao-Li Liu

3

1 reference

14 February 2018

Yun-Chao Hao

4

1 reference

14 February 2018

Yu Li

5

1 reference

14 February 2018

Xia Zhu

6

1 reference

14 February 2018

Fan Zhang

7

1 reference

14 February 2018

Xiao-Xing Yin

8

1 reference

14 February 2018

publication date

18 June 2016

1 reference

14 February 2018

published in

Molecular Neurobiology

1 reference

14 February 2018

volume

54

1 reference

14 February 2018

page(s)

4060-4070

1 reference

14 February 2018

issue

6

1 reference

14 February 2018

https://scigraph.springernature.com/pub.10.1007/s12035-016-9978-z

exact match

0 references

cites work

Dicarbonyl intermediates in the maillard reaction.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9978-Z

Methylglyoxal induces oxidative stress-dependent cell injury and up-regulation of interleukin-1beta and nerve growth factor in cultured hippocampal neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9978-Z

Methylglyoxal causes strong weakening of detoxifying capacity and apoptotic cell death in rat hippocampal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9978-Z

Dicarbonyls linked to damage in the powerhouse: glycation of mitochondrial proteins and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9978-Z

Methylglyoxal promotes oxidative stress and endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9978-Z

Methylglyoxal mediates vascular inflammation via JNK and p38 in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9978-Z

Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9978-Z

Mild oxidative damage in the diabetic rat heart is attenuated by glyoxalase-1 overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9978-Z

Overexpression of glyoxalase-I reduces hyperglycemia-induced levels of advanced glycation end products and oxidative stress in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9978-Z

Increased glyoxalase I levels inhibit accumulation of oxidative stress and an advanced glycation end product in mouse mesangial cells cultured in high glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9978-Z

Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9978-Z

Suppression of methylglyoxal hyperactivity by mangiferin can prevent diabetes-associated cognitive decline in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9978-Z

Up-regulation of glyoxalase 1 by mangiferin prevents diabetic nephropathy progression in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9978-Z

Fisetin lowers methylglyoxal dependent protein glycation and limits the complications of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9978-Z

Glyoxalase 1 and glyoxalase 2 activities in blood and neuronal tissue samples from experimental animal models of obesity and type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9978-Z

Nrf2-dependent gene expressions: a molecular toxicological aspect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9978-Z

Transcriptional control of glyoxalase 1 by Nrf2 provides a stress-responsive defence against dicarbonyl glycation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9978-Z

Neuroprotection by two polyphenols following excitotoxicity and experimental ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9978-Z

Mangiferin ameliorates scopolamine-induced learning deficits in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9978-Z

Mangiferin decreases inflammation and oxidative damage in rat brain after stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9978-Z

Mangiferin, a naturally occurring glucoxilxanthone improves long-term object recognition memory in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9978-Z

Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9978-Z

Mangiferin exerts hepatoprotective activity against D-galactosamine induced acute toxicity and oxidative/nitrosative stress via Nrf2-NFκB pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9978-Z

Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9978-Z

Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9978-Z

Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9978-Z

The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9978-Z

Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9978-Z

Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose

21 January 2018

1 reference

12 December 2020

Prevention of diabetic nephropathy by sulforaphane: possible role of Nrf2 upregulation and activation

1 reference

12 December 2020

Mangiferin prevents diabetic nephropathy progression in streptozotocin-induced diabetic rats

1 reference

12 December 2020

The Critical Role of Methylglyoxal and Glyoxalase 1 in Diabetic Nephropathy

1 reference

12 December 2020

Mangiferin activates the Nrf2-ARE pathway and reduces etoposide-induced DNA damage in human umbilical cord mononuclear blood cells

1 reference

12 December 2020

Prevention of diabetic complications by activation of Nrf2: diabetic cardiomyopathy and nephropathy

1 reference

12 December 2020

Role of mangiferin on biochemical alterations and antioxidant status in isoproterenol-induced myocardial infarction in rats

1 reference

12 December 2020

10.1007/S12035-016-9978-Z

Identifiers

DOI

1 reference

14 February 2018

PubMed ID

27318675

1 reference

14 February 2018